Sphera Funds Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-500,000
| Closed | -$763K | – | 82 |
|
2019
Q3 | $763K | Hold |
500,000
| – | – | 0.12% | 72 |
|
2019
Q2 | $1.04M | Buy |
+500,000
| New | +$1.04M | 0.14% | 73 |
|
2018
Q4 | – | Sell |
-40,000
| Closed | -$378K | – | 100 |
|
2018
Q3 | $378K | Buy |
+40,000
| New | +$378K | 0.04% | 101 |
|
2017
Q1 | – | Sell |
-22,000
| Closed | -$54K | – | 105 |
|
2016
Q4 | $54K | Sell |
22,000
-278,000
| -93% | -$682K | 0.01% | 98 |
|
2016
Q3 | $1.03M | Hold |
300,000
| – | – | 0.17% | 88 |
|
2016
Q2 | $1.04M | Sell |
300,000
-154,500
| -34% | -$538K | 0.27% | 70 |
|
2016
Q1 | $1.88M | Hold |
454,500
| – | – | 0.41% | 50 |
|
2015
Q4 | $2.02M | Sell |
454,500
-50,500
| -10% | -$225K | 0.3% | 79 |
|
2015
Q3 | $3.08M | Buy |
505,000
+250,000
| +98% | +$1.52M | 0.39% | 47 |
|
2015
Q2 | $3.02M | Sell |
255,000
-43,486
| -15% | -$516K | 0.3% | 82 |
|
2015
Q1 | $5.21M | Buy |
298,486
+123,486
| +71% | +$2.16M | 0.54% | 32 |
|
2014
Q4 | $2.65M | Buy |
+175,000
| New | +$2.65M | 0.45% | 73 |
|